Inmune Bio (INMB) EBT Margin (2021 - 2025)
Historic EBT Margin for Inmune Bio (INMB) over the last 5 years, with Q1 2025 value amounting to 19810.0%.
- Inmune Bio's EBT Margin rose 588828600.0% to 19810.0% in Q1 2025 from the same period last year, while for Sep 2025 it was 102752.0%, marking a year-over-year decrease of 38305700.0%. This contributed to the annual value of 304535.71% for FY2024, which is 2851757100.0% down from last year.
- Inmune Bio's EBT Margin amounted to 19810.0% in Q1 2025, which was up 588828600.0% from 78692.86% recorded in Q1 2024.
- In the past 5 years, Inmune Bio's EBT Margin registered a high of 3974.23% during Q1 2022, and its lowest value of 113700.0% during Q1 2021.
- For the 5-year period, Inmune Bio's EBT Margin averaged around 32314.32%, with its median value being 19810.0% (2025).
- Per our database at Business Quant, Inmune Bio's EBT Margin surged by 1097257700bps in 2022 and then tumbled by -617902300bps in 2024.
- Inmune Bio's EBT Margin (Quarter) stood at 5539.88% in 2021, then decreased by -5bps to 5816.49% in 2022, then plummeted by -414bps to 29925.0% in 2023, then tumbled by -163bps to 78692.86% in 2024, then soared by 75bps to 19810.0% in 2025.
- Its EBT Margin was 19810.0% in Q1 2025, compared to 78692.86% in Q1 2024 and 29925.0% in Q4 2023.